↓ Skip to main content

The extracellular volume status predicts body fluid response to SGLT2 inhibitor dapagliflozin in diabetic kidney disease

Overview of attention for article published in Diabetology & Metabolic Syndrome, May 2020
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
36 Dimensions

Readers on

mendeley
49 Mendeley